103 related articles for article (PubMed ID: 35803570)
1. Decision Tree Model for Predicting the Overall Survival of Patients with Diffused Large B-Cell Lymphoma in the Central Nervous System.
Huang H; Yang ZH; Gu ZW; Luo M; Xu L
World Neurosurg; 2022 Oct; 166():e189-e198. PubMed ID: 35803570
[TBL] [Abstract][Full Text] [Related]
2. Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based Study.
Wang J; Zhou M; Zhou R; Xu J; Chen B
Front Oncol; 2020; 10():1093. PubMed ID: 32719748
[No Abstract] [Full Text] [Related]
3. Prognostic significance of pretreatment red blood cell distribution width in primary diffuse large B-cell lymphoma of the central nervous system for 3P medical approaches in multiple cohorts.
Li D; Li S; Xia Z; Cao J; Zhang J; Chen B; Zhang X; Zhu W; Fang J; Liu Q; Hua W
EPMA J; 2022 Sep; 13(3):499-517. PubMed ID: 36061828
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma.
Zhong Q; Shi Y
Front Oncol; 2020; 10():582567. PubMed ID: 33520698
[TBL] [Abstract][Full Text] [Related]
5. A visual model for prognostic estimation in patients with primary diffuse large B-cell lymphoma of small intestine and colon: analysis of 1,613 cases from the SEER database.
Wang Y; Song J; Wen S; Zhang X
Transl Cancer Res; 2021 Apr; 10(4):1842-1855. PubMed ID: 35116506
[TBL] [Abstract][Full Text] [Related]
6. [Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].
Zhou J; Xia C; Shen Q; Yin H; Zhang X; Shi Q; Zhou X; Ma J
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):8-14. PubMed ID: 24713242
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and prognosis of 49 newly diagnosed primary central nervous system diffuse large B-cell lymphoma].
Song J; Liu H; Shen HL; Yue LZ; Yang XJ; Song WJ; Sun CY; Yu SZ; Ding K; Wang YH; Li LJ; Yu H; Shao YY; Wang CM; Yue SY; Fu R
Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):917-922. PubMed ID: 35045653
[No Abstract] [Full Text] [Related]
8. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
9. Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B-cell lymphoma.
Li X; Sun X; Li J; Liu Z; Mi M; Zhu F; Wu G; Lan X; Zhang L
Cancer Med; 2019 Sep; 8(11):5012-5022. PubMed ID: 31293092
[TBL] [Abstract][Full Text] [Related]
10. [Construction and validation of a decision tree based on biomarkers for predicting severe acute kidney injury in critically ill patients].
Chi R; Liang M; Zou Q; Li C; Zhou H; Jian Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):721-725. PubMed ID: 32684220
[TBL] [Abstract][Full Text] [Related]
11. An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy.
Hu J; Xu J; Yu M; Gao Y; Liu R; Zhou H; Zhang W
J Transl Med; 2020 Mar; 18(1):144. PubMed ID: 32228625
[TBL] [Abstract][Full Text] [Related]
12. Baseline
Aide N; Fruchart C; Nganoa C; Gac AC; Lasnon C
Eur Radiol; 2020 Aug; 30(8):4623-4632. PubMed ID: 32248365
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein to albumin ratio is a key indicator in a predictive model for anastomosis leakage after esophagectomy: Application of classification and regression tree analysis.
Shao CY; Liu KC; Li CL; Cong ZZ; Hu LW; Luo J; Diao YF; Xu Y; Ji SG; Qiang Y; Shen Y
Thorac Cancer; 2019 Apr; 10(4):728-737. PubMed ID: 30734487
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of the addition of rituximab to CHOP in young patients with good-prognosis diffuse large-B-cell lymphoma.
Ferrara F; Ravasio R
Clin Drug Investig; 2008; 28(1):55-65. PubMed ID: 18081361
[TBL] [Abstract][Full Text] [Related]
15. A Novel Prognostic Model for Patients with Primary Gastric Diffuse Large B-Cell Lymphoma.
Lu G; Lin Z; Ruan Y; Huang H; Lin J; Pan J
J Oncol; 2022; 2022():9636790. PubMed ID: 36339648
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma].
Wang X; Wang CY; Xu W; Yang HL; Zhao HF; Wang XF; Wang YF; Yu Y; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):52-60. PubMed ID: 30738447
[TBL] [Abstract][Full Text] [Related]
17. Combined Visual and Semiquantitative Evaluation Improves Outcome Prediction by Early Midtreatment
Györke T; Carr R; Cerci JJ; Meneghetti C; Redondo F; Celli M; Gorospe C; Auewarakul CU; Jorgov L; Paez D; Fanti S
J Nucl Med; 2020 Jul; 61(7):999-1005. PubMed ID: 31757842
[TBL] [Abstract][Full Text] [Related]
18. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
19. Recursive Partitioning Analysis (RPA) of Prognostic Factors for Overall Survival in Patients with Spinal Metastasis: A New System for Stratified Treatment.
Yang XG; Wang F; Feng JT; Hu YC; Lun DX; Hua KC; Liu YH; Zhang H; Yang L
World Neurosurg; 2019 Jul; 127():e124-e131. PubMed ID: 30862584
[TBL] [Abstract][Full Text] [Related]
20. Interim response in diffuse large B cell lymphoma on CT: what is the optimal size reduction (ΔSPD) for predicting outcome?
Wei YC; Ding CY; Liang JH; Wang L; Zhu HY; Xia Y; Wu JZ; Fan L; Li TN; Li JY; Xu W
Eur Radiol; 2020 Jun; 30(6):3094-3100. PubMed ID: 32065283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
